Show simple item record

dc.contributor.authorEspantoso-Romero, Maite
dc.contributor.authorRoman-Rodriguez, Miguel
dc.contributor.authorDuarte-Perez, Ana
dc.contributor.authorGonzalvez-Rey, Jaime
dc.contributor.authorCallejas-Cabanillas, Pedro A
dc.contributor.authorLazic, Durdica Kasuba
dc.contributor.authorAnta-Agudo, Berta
dc.contributor.authorToran Monserrat, Pere
dc.contributor.authorMagallon-Botaya, Rosa
dc.contributor.authorKitanovska, Biljana Gerasimovska
dc.contributor.authorLingner, Heidrun
dc.contributor.authorAssenova, Radost S
dc.contributor.authorIftode, Claudia
dc.contributor.authorGude-Sampedro, Francisco
dc.contributor.authorClaveria, Ana
dc.contributor.authorPROEPOC COPD Study Grp
dc.date.accessioned2024-07-09T09:14:22Z
dc.date.available2024-07-09T09:14:22Z
dc.date.issued2016-11-11
dc.identifier.citationEspantoso-Romero M, Román-Rodríguez M, Duarte-Perez A, Gonzalvez-Rey J, Callejas-Cabanillas PA, Lazic Durdica K, et al. External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort). BMC Pulm Med. 2016 Nov 11;16:143.en
dc.identifier.issn1471-2466
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/10085
dc.identifier.urihttp://hdl.handle.net/20.500.12105/20296
dc.description.abstractBackground: Due to the heterogeneous and systemic nature of the chronic obstructive pulmonary disease ( COPD), the new guidelines are oriented toward individualized attention. Multidimensional scales could facilitate its proper clinical and prognostic assessment, but not all of them were validated in an international primary care cohort, different from the original ones used for model development. Therefore, our main aim is to assess the prognostic capacity of the ADO, BODEx and DOSE indices in primary care for predicting mortality in COPD patients and to validate the models obtained in subgroups of patients, classified by revised Global Initiative for Chronic Obstructive Lung Disease ( 2011) and updated Spanish Guideline ( 2014). Besides, we want to confirm that the prognostic capacity of all indices increases if the number of exacerbations is substituted by the interval between them and to assess the impact on health of the patient's lifestyle, social network and adherence to treatment. Methods: Design: External validation of scales, open and prospective cohort study in primary care. Setting: 36 health centres in 6 European high, medium and low income countries. Subjects: 477 patients diagnosed with COPD, captured in clinical visit by their General Practitioner/Nurse. Predictors: Detailed patient history, exacerbations, lung function test and questionnaires at baseline. Outcomes: Exacerbations, all-cause mortality and specific mortality, within 5 years of recruitment. Analysis: Multivariate logistic regression and Cox regression will be used. Possible non-linear effect of the indices will be studied by using Structured Additive Regression models with penalised splines. Subsequently, we will assess different aspects of the regression models: discrimination, calibration and diagnostic precision. Clinical variables modulated in primary care and the interval between exacerbations will be considered and incorporated into the analysis. Discussion: The Research Agenda for General Practice/Family Medicine highlights that the evidence on predictive values of prognostic indices in primary care is scarce. A prospective cohort like that of PROEPOC/COPD provides good opportunities for research into COPD and make communication easier between family practitioners, nursing staff, pneumologists and other professionals, supporting a multi-disciplinary approach to the treatment of these patients.en
dc.description.sponsorshipThe PROEPOC/COPD study is supported by a grant (PI14/00385) from the Instituto de Salud Carlos III (Carlos III Institute of Health) of the Spanish Ministry of Health, co-financed with European Union ERDF Funds, in peer reviewed public competition.es_ES
dc.language.isoengen
dc.publisherBioMed Central (BMC) en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectChronic obstructive pulmonary disease
dc.subjectValidation studies as topic
dc.subjectPrimary health care
dc.subjectPrognosis
dc.subject.meshDisease Progression *
dc.subject.meshRisk Assessment *
dc.subject.meshPulmonary Disease, Chronic Obstructive *
dc.subject.meshHumans *
dc.subject.meshPrognosis *
dc.subject.meshRespiratory Function Tests *
dc.subject.meshMultivariate Analysis *
dc.subject.meshSeverity of Illness Index *
dc.subject.meshProspective Studies *
dc.subject.meshEurope *
dc.subject.meshRisk Factors *
dc.subject.meshProportional Hazards Models *
dc.subject.meshPrimary Health Care *
dc.subject.meshSurveys and Questionnaires *
dc.subject.meshLogistic Models *
dc.titleExternal validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort)en
dc.typeresearch articleen
dc.rights.licenseAttribution 4.0 International*
dc.identifier.pubmedID27835945es_ES
dc.format.volume16es_ES
dc.format.page143es_ES
dc.identifier.doi10.1186/s12890-016-0305-2
dc.relation.publisherversionhttps://dx.doi.org/10.1186/s12890-016-0305-2en
dc.identifier.journalBMC Pulmonary Medicinees_ES
dc.rights.accessRightsopen accessen
dc.subject.decsModelos de Riesgos Proporcionales*
dc.subject.decsModelos Logísticos*
dc.subject.decsAnálisis Multivariante*
dc.subject.decsEuropa (Continente)*
dc.subject.decsEnfermedad Pulmonar Obstructiva Crónica*
dc.subject.decsFactores de Riesgo*
dc.subject.decsHumanos*
dc.subject.decsPruebas de Función Respiratoria*
dc.subject.decsEstudios Prospectivos*
dc.subject.decsPronóstico*
dc.subject.decsMedición de Riesgo*
dc.subject.decsÍndice de Severidad de la Enfermedad*
dc.subject.decsProgresión de la Enfermedad*
dc.subject.decsEncuestas y Cuestionarios*
dc.subject.decsAtención Primaria de Salud*
dc.identifier.scopus2-s2.0-85001130055
dc.identifier.wos388035500001
dc.identifier.puiL613156773


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
This item is licensed under a: Attribution 4.0 International